Compare $HAE vs $QDEL | Chartloom

Compare

$HAE vs $QDEL

Haemonetics Corp · QuidelOrtho Corp

HAE

Haemonetics Corp

QDEL

QuidelOrtho Corp

Compare $HAE vs $QDEL

Comparing Haemonetics Corp and QuidelOrtho Corp

HAEHaemonetics Corp

QDELQuidelOrtho Corp

HAEHaemonetics Corp

Market cap

$5.39B

P/E (TTM)

56.34x

Forward P/E (NTM)

21.33x

Forward P/S (NTM)

3.72x

Rev growth (TTM)

0.4%

YTD performance

48.4%

52W performance

132.8%

FCF yield

4.5%

QDELQuidelOrtho Corp

Market cap

$915M

P/E (TTM)

—

Forward P/E (NTM)

15.21x

Forward P/S (NTM)

0.35x

Rev growth (TTM)

-2.5%

YTD performance

-53.4%

52W performance

-51.8%

FCF yield

-23.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HAE

QDEL

Detailed metrics comparison

HAE

Haemonetics Corp

QDEL

QuidelOrtho Corp

Market Cap

HAE$5.39B

QDEL$915M

Enterprise Value

HAE$6.35B

QDEL$3.68B

Price

HAE$118.69

QDEL$13.42

P/E Ratio

HAE56.34x

QDELN/A

P/S Ratio

HAE3.99x

QDEL0.34x

EV/Sales

HAE4.69x

QDEL1.38x

EV/EBITDA

HAE17.94x

QDEL8.78x

P/B Ratio

HAE5.69x

QDEL0.42x

P/FCF Ratio

HAE22.00x

QDELN/A

EV/FCF

HAE25.88x

QDEL-17.44x

PEG Ratio

HAEN/A

QDELN/A

Forward P/E (NTM)

HAE21.33x

QDEL15.21x

Forward P/S (NTM)

HAE3.72x

QDEL0.35x

Revenue (TTM)

HAE$1.35B

QDEL$2.67B

Revenue Growth (YoY)

HAE0.4%

QDEL-2.5%

Forward Rev Growth

HAE5.2%

QDEL1.8%

Gross Margin (TTM)

HAE59.1%

QDEL44.6%

Operating Margin (TTM)

HAE11.9%

QDEL0.0%

EBITDA Margin (TTM)

HAE26.2%

QDEL15.7%

Net Margin (TTM)

HAE7.1%

QDEL-39.2%

FCF Margin (TTM)

HAE18.1%

QDEL-7.9%

Net Income (TTM)

HAE$96M

QDEL$-1.05B

FCF (TTM)

HAE$245M

QDEL$-211M

EPS (TTM)

HAE$2.11

QDEL-$15.35

ROE (TTM)

HAE11.3%

QDEL-5530.0%

ROA (TTM)

HAE4.0%

QDEL-1840.0%

ROIC (TTM)

HAE4.7%

QDEL-2270.0%

Cash

HAE$223M

QDEL$123M

Debt

HAE$1.17B

QDEL$2.89B

Net Cash/Debt

HAE$-951M

QDEL$-2.77B

Current Ratio (TTM)

HAE3.08x

QDEL1.39x

Quick Ratio (TTM)

HAE1.67x

QDEL0.66x

Debt/Equity (TTM)

HAE1.40x

QDEL1.63x

Debt/Assets (TTM)

HAE0.0%

QDEL0.0%

Interest Coverage (TTM)

HAEN/A

QDELN/A

Net Debt/EBITDA (TTM)

HAE0.00x

QDEL0.00x

Beta

HAE0.62

QDEL0.85

52W Performance

HAE132.8%

QDEL-51.8%

YTD Performance

HAE48.4%

QDEL-53.4%

% from 52W High

HAE-2.1%

QDEL-62.3%

% from 52W Low

HAE146.4%

QDEL35.3%

Asset Turnover (TTM)

HAE0.56x

QDEL0.47x

FCF Yield (TTM)

HAE4.5%

QDEL-23.1%

Earnings Yield (TTM)

HAE1.8%

QDEL-114.6%

Dividend Yield (TTM)

HAEN/A

QDELN/A

Rule of 40

HAE18.6

QDEL-10.4

EV/GP/RG

HAE1.08

QDEL1.67

Ticker research

View HAE research View QDEL research

Metric	HAE Haemonetics Corp	QDEL QuidelOrtho Corp
Market & Valuation
Market Cap	$5.39B	$915M
Enterprise Value	$6.35B	$3.68B
Price	$118.69	$13.42
P/E Ratio	56.34x	N/A
P/S Ratio	3.99x	0.34x
EV/Sales	4.69x	1.38x
EV/EBITDA	17.94x	8.78x
P/B Ratio	5.69x	0.42x
P/FCF Ratio	22.00x	N/A
EV/FCF	25.88x	-17.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	21.33x	15.21x
Forward P/S (NTM)	3.72x	0.35x
Revenue & Growth
Revenue (TTM)	$1.35B	$2.67B
Revenue Growth (YoY)	0.4%	-2.5%
Forward Rev Growth	5.2%	1.8%
Profitability
Gross Margin (TTM)	59.1%	44.6%
Operating Margin (TTM)	11.9%	0.0%
EBITDA Margin (TTM)	26.2%	15.7%
Net Margin (TTM)	7.1%	-39.2%
FCF Margin (TTM)	18.1%	-7.9%
Net Income (TTM)	$96M	$-1.05B
FCF (TTM)	$245M	$-211M
EPS (TTM)	$2.11	-$15.35
ROE (TTM)	11.3%	-5530.0%
ROA (TTM)	4.0%	-1840.0%
ROIC (TTM)	4.7%	-2270.0%
Financial Health
Cash	$223M	$123M
Debt	$1.17B	$2.89B
Net Cash/Debt	$-951M	$-2.77B
Current Ratio (TTM)	3.08x	1.39x
Quick Ratio (TTM)	1.67x	0.66x
Debt/Equity (TTM)	1.40x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.85
52W Performance	132.8%	-51.8%
YTD Performance	48.4%	-53.4%
% from 52W High	-2.1%	-62.3%
% from 52W Low	146.4%	35.3%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.47x
FCF Yield (TTM)	4.5%	-23.1%
Earnings Yield (TTM)	1.8%	-114.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.6	-10.4
EV/GP/RG	1.08	1.67
Ticker research	View HAE research	View QDEL research

Valuation

P/E Ratio

HAE

56.34x

P/S Ratio

QDEL

0.34x

HAE

3.99x

EV/FCF

QDEL

-17.44x

HAE

25.88x

Growth & revenue

Revenue Growth TTM

HAE

0.4%

QDEL

-2.5%

Forward Revenue Growth

HAE

5.2%

QDEL

1.8%

Profitability & performance

Gross Margin

HAE

59.1%

QDEL

44.6%

ROE

HAE

11.3%

QDEL

-5530.0%

FCF Yield %

HAE

4.5%

QDEL

-23.1%

52-Week Performance

HAE

132.8%

QDEL

-51.8%

Detailed metrics comparison

HAE

Haemonetics Corp

QDEL

QuidelOrtho Corp

Market Cap

HAE$5.39B

QDEL$915M

Enterprise Value

HAE$6.35B

QDEL$3.68B

Price

HAE$118.69

QDEL$13.42

P/E Ratio

HAE56.34x

QDELN/A

P/S Ratio

HAE3.99x

QDEL0.34x

EV/Sales

HAE4.69x

QDEL1.38x

EV/EBITDA

HAE17.94x

QDEL8.78x

P/B Ratio

HAE5.69x

QDEL0.42x

P/FCF Ratio

HAE22.00x

QDELN/A

EV/FCF

HAE25.88x

QDEL-17.44x

PEG Ratio

HAEN/A

QDELN/A

Forward P/E (NTM)

HAE21.33x

QDEL15.21x

Forward P/S (NTM)

HAE3.72x

QDEL0.35x

Revenue (TTM)

HAE$1.35B

QDEL$2.67B

Revenue Growth (YoY)

HAE0.4%

QDEL-2.5%

Forward Rev Growth

HAE5.2%

QDEL1.8%

Gross Margin (TTM)

HAE59.1%

QDEL44.6%

Operating Margin (TTM)

HAE11.9%

QDEL0.0%

EBITDA Margin (TTM)

HAE26.2%

QDEL15.7%

Net Margin (TTM)

HAE7.1%

QDEL-39.2%

FCF Margin (TTM)

HAE18.1%

QDEL-7.9%

Net Income (TTM)

HAE$96M

QDEL$-1.05B

FCF (TTM)

HAE$245M

QDEL$-211M

EPS (TTM)

HAE$2.11

QDEL-$15.35

ROE (TTM)

HAE11.3%

QDEL-5530.0%

ROA (TTM)

HAE4.0%

QDEL-1840.0%

ROIC (TTM)

HAE4.7%

QDEL-2270.0%

Cash

HAE$223M

QDEL$123M

Debt

HAE$1.17B

QDEL$2.89B

Net Cash/Debt

HAE$-951M

QDEL$-2.77B

Current Ratio (TTM)

HAE3.08x

QDEL1.39x

Quick Ratio (TTM)

HAE1.67x

QDEL0.66x

Debt/Equity (TTM)

HAE1.40x

QDEL1.63x

Debt/Assets (TTM)

HAE0.0%

QDEL0.0%

Interest Coverage (TTM)

HAEN/A

QDELN/A

Net Debt/EBITDA (TTM)

HAE0.00x

QDEL0.00x

Beta

HAE0.62

QDEL0.85

52W Performance

HAE132.8%

QDEL-51.8%

YTD Performance

HAE48.4%

QDEL-53.4%

% from 52W High

HAE-2.1%

QDEL-62.3%

% from 52W Low

HAE146.4%

QDEL35.3%

Asset Turnover (TTM)

HAE0.56x

QDEL0.47x

FCF Yield (TTM)

HAE4.5%

QDEL-23.1%

Earnings Yield (TTM)

HAE1.8%

QDEL-114.6%

Dividend Yield (TTM)

HAEN/A

QDELN/A

Rule of 40

HAE18.6

QDEL-10.4

EV/GP/RG

HAE1.08

QDEL1.67

Ticker research

View HAE research View QDEL research

Metric	HAE Haemonetics Corp	QDEL QuidelOrtho Corp
Market & Valuation
Market Cap	$5.39B	$915M
Enterprise Value	$6.35B	$3.68B
Price	$118.69	$13.42
P/E Ratio	56.34x	N/A
P/S Ratio	3.99x	0.34x
EV/Sales	4.69x	1.38x
EV/EBITDA	17.94x	8.78x
P/B Ratio	5.69x	0.42x
P/FCF Ratio	22.00x	N/A
EV/FCF	25.88x	-17.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	21.33x	15.21x
Forward P/S (NTM)	3.72x	0.35x
Revenue & Growth
Revenue (TTM)	$1.35B	$2.67B
Revenue Growth (YoY)	0.4%	-2.5%
Forward Rev Growth	5.2%	1.8%
Profitability
Gross Margin (TTM)	59.1%	44.6%
Operating Margin (TTM)	11.9%	0.0%
EBITDA Margin (TTM)	26.2%	15.7%
Net Margin (TTM)	7.1%	-39.2%
FCF Margin (TTM)	18.1%	-7.9%
Net Income (TTM)	$96M	$-1.05B
FCF (TTM)	$245M	$-211M
EPS (TTM)	$2.11	-$15.35
ROE (TTM)	11.3%	-5530.0%
ROA (TTM)	4.0%	-1840.0%
ROIC (TTM)	4.7%	-2270.0%
Financial Health
Cash	$223M	$123M
Debt	$1.17B	$2.89B
Net Cash/Debt	$-951M	$-2.77B
Current Ratio (TTM)	3.08x	1.39x
Quick Ratio (TTM)	1.67x	0.66x
Debt/Equity (TTM)	1.40x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.85
52W Performance	132.8%	-51.8%
YTD Performance	48.4%	-53.4%
% from 52W High	-2.1%	-62.3%
% from 52W Low	146.4%	35.3%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.47x
FCF Yield (TTM)	4.5%	-23.1%
Earnings Yield (TTM)	1.8%	-114.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.6	-10.4
EV/GP/RG	1.08	1.67
Ticker research	View HAE research	View QDEL research